SARILUMAB Pharmacologic Class Indexing

Class set ID
5f3dab22-47a8-4aa9-971a-2f0c1b76507d
Version
2
Effective date
20180813
Type
Indexing - Pharmacologic Class

Mapped DailyMed Labels#

Label, Manufacturer, Effective table
LabelManufacturerEffectiveSPL version
These highlights do not include all the information needed to use KEVZARA ® safely and effectively. See full prescribing information for KEVZARA. KEVZARA (sarilumab) injection, for subcutaneous use Initial U.S. Approval: 2017Sanofi-Aventis U.S. LLC | Sanofi Winthrop Industrie | Sanofi-Aventis Deutschland GmbH | Regeneron Pharmaceuticals, Inc. | Genzyme Corporation | Genzyme Ireland Limited | Nelson Laboratories, LLC2026022715